Veeva Systems (VEEV) Stock Forecast & Price Target

Compare

4,557 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VEEV Analyst Ratings

Moderate Buy

15 Buy

8 Hold

1 Sell

Based on 24 analysts giving stock ratings to

Veeva

Systems

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VEEV Stock 12 Month Forecast

Average Price Target

$300.64

▲(4.92% Upside)

Based on 24 Wall Street analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is $300.64 with a high forecast of $335.00 and a low forecast of $210.00. The average price target represents a 4.92% change from the last price of $286.54.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"188":"$188","225":"$225","262":"$262","299":"$299","336":"$336"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":335,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$335.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":300.64,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$300.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":210,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$210.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[188,225,262,299,336],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,281.35,285.4769230769231,289.6038461538462,293.7307692307692,297.85769230769233,301.9846153846154,306.1115384615385,310.23846153846154,314.36538461538464,318.4923076923077,322.6192307692308,326.74615384615385,330.87307692307695,{"y":335,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,281.35,282.8338461538462,284.3176923076923,285.8015384615385,287.2853846153846,288.7692307692308,290.25307692307695,291.73692307692306,293.22076923076924,294.7046153846154,296.1884615384615,297.6723076923077,299.1561538461538,{"y":300.64,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,281.35,275.8615384615385,270.37307692307695,264.8846153846154,259.3961538461539,253.90769230769232,248.41923076923078,242.93076923076924,237.4423076923077,231.95384615384614,226.4653846153846,220.97692307692307,215.48846153846154,{"y":210,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":189.14,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.44,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":212.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.46,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.26,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":224.14,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.9,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":232.07,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.63,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":282.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":281.35,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$335.00

Average Price Target$300.64

Lowest Price Target$210.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stan Berenshteyn

Wells Fargo

$300→$326

Buy

13.77%

Upside

Reiterated

08/26/25

Analysts Offer Insights on Healthcare Companies: AxoGen (NASDAQ: AXGN) and Veeva Systems (NYSE: VEEV)

Brian Peterson

Raymond James

$310

Buy

8.19%

Upside

Reiterated

08/25/25

Raymond James Keeps Their Buy Rating on Veeva Systems (VEEV)Raymond James analyst Brian Peterson reiterated an Outperform rating and $310.00 price target on Veeva Systems (NYSE: VEEV).

Craig Hettenbach

Morgan Stanley

$210

Sell

-26.71%

Downside

Reiterated

08/21/25

Cautious Outlook on Veeva Systems Amid Growth Sustainability Concerns and Sector Risks

Jailendra Singh

Truist Financial

$230→$268

Hold

-6.47%

Downside

Reiterated

08/21/25

Veeva Systems: Hold Rating Amid High Expectations and Macroeconomic Concerns

Joseph Vruwink

Robert W. Baird

$297→$310

Buy

8.19%

Upside

Reiterated

08/20/25

Robert W. Baird Sticks to Their Buy Rating for Veeva Systems (VEEV)

Saket Kalia

Barclays

$300

Buy

4.70%

Upside

Reiterated

08/19/25

Barclays Sticks to Its Buy Rating for Veeva Systems (VEEV)

Isla Carelynx

TR | OpenAI - 4o

$314→$319

Buy

11.33%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Rishi Jaluria

RBC Capital

$330

Buy

15.17%

Upside

Reiterated

08/18/25

RBC Capital Remains a Buy on Veeva Systems (VEEV)

Kenneth Wong

Oppenheimer

$325

Buy

13.42%

Upside

Reiterated

07/29/25

Analysts Conflicted on These Healthcare Names: Icon (NASDAQ: ICLR) and Veeva Systems (NYSE: VEEV)

Dylan Becker

William Blair

―

Buy

―

Reiterated

07/21/25

Veeva Systems' Strong Market Position and Growth Potential: A Buy Rating by Dylan Becker

Charles Rhyee

TD Cowen

$284

Hold

-0.89%

Downside

Reiterated

07/17/25

Analysts Offer Insights on Healthcare Companies: Novartis (NYSE: NVS), Regeneron (NASDAQ: REGN) and Veeva Systems (NYSE: VEEV)

Allan Verkhovski

Scotiabank

―

Hold

―

Reiterated

06/30/25

Analysts Conflicted on These Healthcare Names: OS Therapies Incorporated (NYSE MKT: OSTX), Korro Bio (NASDAQ: KRRO) and Veeva Systems (NYSE: VEEV)

Anne Samuel

J.P. Morgan

$249→$274

Hold

-4.38%

Downside

Reiterated

06/04/25

J.P. Morgan Sticks to Their Hold Rating for Veeva Systems (VEEV)

David Windley

Jefferies

$280→$335

Buy

16.91%

Upside

Reiterated

06/02/25

Jefferies Remains a Buy on Veeva Systems (VEEV)

Steven Valiquette

Mizuho Securities

$280→$295

Buy

2.95%

Upside

Reiterated

06/02/25

Veeva price target raised to $295 from $280 at MizuhoVeeva price target raised to $295 from $280 at Mizuho

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stan Berenshteyn

Wells Fargo

$300→$326

Buy

13.77%

Upside

Reiterated

08/26/25

Analysts Offer Insights on Healthcare Companies: AxoGen (NASDAQ: AXGN) and Veeva Systems (NYSE: VEEV)

Brian Peterson

Raymond James

$310

Buy

8.19%

Upside

Reiterated

08/25/25

Raymond James Keeps Their Buy Rating on Veeva Systems (VEEV)Raymond James analyst Brian Peterson reiterated an Outperform rating and $310.00 price target on Veeva Systems (NYSE: VEEV).

Craig Hettenbach

Morgan Stanley

$210

Sell

-26.71%

Downside

Reiterated

08/21/25

Cautious Outlook on Veeva Systems Amid Growth Sustainability Concerns and Sector Risks

Jailendra Singh

Truist Financial

$230→$268

Hold

-6.47%

Downside

Reiterated

08/21/25

Veeva Systems: Hold Rating Amid High Expectations and Macroeconomic Concerns

Joseph Vruwink

Robert W. Baird

$297→$310

Buy

8.19%

Upside

Reiterated

08/20/25

Robert W. Baird Sticks to Their Buy Rating for Veeva Systems (VEEV)

Saket Kalia

Barclays

$300

Buy

4.70%

Upside

Reiterated

08/19/25

Barclays Sticks to Its Buy Rating for Veeva Systems (VEEV)

Isla Carelynx

TR | OpenAI - 4o

$314→$319

Buy

11.33%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Rishi Jaluria

RBC Capital

$330

Buy

15.17%

Upside

Reiterated

08/18/25

RBC Capital Remains a Buy on Veeva Systems (VEEV)

Kenneth Wong

Oppenheimer

$325

Buy

13.42%

Upside

Reiterated

07/29/25

Analysts Conflicted on These Healthcare Names: Icon (NASDAQ: ICLR) and Veeva Systems (NYSE: VEEV)

Dylan Becker

William Blair

―

Buy

―

Reiterated

07/21/25

Veeva Systems' Strong Market Position and Growth Potential: A Buy Rating by Dylan Becker

Charles Rhyee

TD Cowen

$284

Hold

-0.89%

Downside

Reiterated

07/17/25

Analysts Offer Insights on Healthcare Companies: Novartis (NYSE: NVS), Regeneron (NASDAQ: REGN) and Veeva Systems (NYSE: VEEV)

Allan Verkhovski

Scotiabank

―

Hold

―

Reiterated

06/30/25

Analysts Conflicted on These Healthcare Names: OS Therapies Incorporated (NYSE MKT: OSTX), Korro Bio (NASDAQ: KRRO) and Veeva Systems (NYSE: VEEV)

Anne Samuel

J.P. Morgan

$249→$274

Hold

-4.38%

Downside

Reiterated

06/04/25

J.P. Morgan Sticks to Their Hold Rating for Veeva Systems (VEEV)

David Windley

Jefferies

$280→$335

Buy

16.91%

Upside

Reiterated

06/02/25

Jefferies Remains a Buy on Veeva Systems (VEEV)

Steven Valiquette

Mizuho Securities

$280→$295

Buy

2.95%

Upside

Reiterated

06/02/25

Veeva price target raised to $295 from $280 at MizuhoVeeva price target raised to $295 from $280 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veeva Systems

1 Month

xxx

Success Rate

17/24 ratings generated profit

Average Return

+2.21%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 70.83% of your transactions generating a profit, with an average return of +2.21% per trade.

3 Months

xxx

Success Rate

14/18 ratings generated profit

Average Return

+5.08%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +5.08% per trade.

1 Year

Stan BerenshteynWells Fargo

Success Rate

18/18 ratings generated profit

Average Return

+20.89%

reiterated a buy rating 2 days ago

Copying Stan Berenshteyn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.89% per trade.

2 Years

xxx

Success Rate

24/24 ratings generated profit

Average Return

+35.54%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.54% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VEEV Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, VEEV has received 21 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. VEEV average Analyst price target in the past 3 months is 300.64.

Each month's total comprises the sum of three months' worth of ratings.

VEEV Financial Forecast

VEEV Earnings Forecast

The previous quarter’s earnings for VEEV were $1.19.

VEEV Sales Forecast

The previous quarter’s earnings for VEEV were $789.08M.

VEEV Stock Forecast FAQ

What is VEEV’s average 12-month price target, according to analysts?

Based on analyst ratings, Veeva Systems’s 12-month average price target is 300.64.

What is VEEV’s upside potential, based on the analysts’ average price target?

Veeva Systems has 4.92% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is VEEV a Buy, Sell or Hold?

Veeva Systems has a consensus rating of Moderate Buy which is based on 15 buy ratings, 8 hold ratings and 1 sell ratings.

What is Veeva Systems’s price target?

The average price target for Veeva Systems is 300.64. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $335.00 ,the lowest forecast is $210.00. The average price target represents 4.92% Increase from the current price of $286.54.

What do analysts say about Veeva Systems?

Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.

How can I buy shares of VEEV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Veeva Systems (VEEV) Stock Forecast & Price Target

VEEV Analyst Ratings

VEEV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Veeva Systems

VEEV Analyst Recommendation Trends

VEEV Financial Forecast

VEEV Earnings Forecast

VEEV Sales Forecast

VEEV Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts